Doximity’s stock skyrockets 50% on medical AI excitement. Can the rally last?

Reported by MarketWatch · Published 7 Aug 2026, 11:36 PM MYT (1 hr ago)

Image: MarketWatch

While one analyst thinks Doximity has a compelling AI opportunity, another worries that the company could cannibalize its core business of medical networking.

Source & full coverage: this summary is aggregated from MarketWatch, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at MarketWatch →

Doximity’s stock skyrockets 50% on medical AI excitement. Can the rally last?

Summary

More in Markets

SpaceX’s stock is having one of its best days ever — with the first lockup expiration now behind it

Stocks Rise After Cooler-Than-Expected July Jobs Data

The $1 Million 401(k) Strategy That Doubles Your Annual Payout Before Age 59.5

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling.

Stock Market Rally Powers Ahead; SpaceX, Palantir, Sandisk Are Key Earnings Movers: Weekly Review

Amazon's $220 billion AI bet hits a snag: Trainium 2 chips are only 20 months old and already being replaced